Skip Navigation

This Article
Right arrow Print PDF (3568K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Fong, C.-L. W.
Right arrow Articles by Mark, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fong, C.-L. W.
Right arrow Articles by Mark, D. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1994, Vol. 22, No. 6 1108-1114
© 1994


MOLECULAR BIOLOGY

Identification and characterization of a novel repressor site in the human tumor necrosis factor {alpha} gene

Chin-Lin W. Fong, Ayesha H. Siddiqui+ and David F. Mark*

Department of Microbial Chemotherapeutics and Molecular Genetics, Merck Research Laboratories PO Box 2000, Rahway, NJ 07065, USA

* To whom correspondence should be addressed

Received June 11, 1993. Revised February 17, 1994. Accepted February 17, 1994.

In human monocytic cell lines, tumor necrosis factor {alpha} (TNF{alpha}) expression is induced by phorbol myrlstate acetate (PMA). We have identified positive and negative cls-acting elements in the TNF{alpha} promoter by deletion analysis. Here we present the initial characterization of the repressor element. The repressor element was shown to function in either orientation and at various distances upstream from the positive element of the TNF{alpha} promoter. The TNF{alpha} repressor site (TRS) has been localized to a 25 bp region between base pairs –254 and –230 in the promoter. This region contains a 10 bp sequence with homology to the binding site of the activator protein AP-2. Mutation of the 6 C's of this 10 bp AP-2-llke site abolish TRS repressor function. However, this AP-2-llke site is not a binding site for AP-2 protein based on gel retardation analysis. In addition, a well-characterized AP-2 binding site placed upstream of the positive element of the TNF{alpha} gene did not cause repression. Therefore, this repression is very likely mediated by a novel protein(s) which interacts with the AP-2 consensus site in the TRS.


+Present address: Baxter Diagnostics. Miami. FL 33174, USA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
K. Buranawuti, M. P Boyle, S. Cheng, L. L Steiner, K. McDougal, M D. Fallin, C. Merlo, P. L Zeitlin, B. J Rosenstein, P. J Mogayzel Jr, et al.
Variants in mannose-binding lectin and tumour necrosis factor {alpha} affect survival in cystic fibrosis
J. Med. Genet., March 1, 2007; 44(3): 209 - 214.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. S. Monraats, N. M. M. Pires, A. Schepers, W. R. P. Agema, L. S. M. Boesten, M. R. de Vries, A. H. Zwinderman, M. P. M. de Maat, P. A. F. M. Doevendans, R. J. de Winter, et al.
Tumor necrosis factor-{alpha} plays an important role in restenosis development
FASEB J, December 1, 2005; 19(14): 1998 - 2004.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Neben, J. Mytilineos, T. M. Moehler, A. Preiss, A. Kraemer, A. D. Ho, G. Opelz, and H. Goldschmidt
Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma
Blood, August 28, 2002; 100(6): 2263 - 2265.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. Y. Lee and K. E. Sullivan
Gamma Interferon and Lipopolysaccharide Interact at the Level of Transcription To Induce Tumor Necrosis Factor Alpha Expression
Infect. Immun., May 1, 2001; 69(5): 2847 - 2852.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. K. Rasmussen, S. A. Urhammer, J. N. Jensen, T. Hansen, K. Borch-Johnsen, and O. Pedersen
The -238 and -308 G->A Polymorphisms of the Tumor Necrosis Factor {alpha} Gene Promotor Are Not Associated with Features of the Insulin Resistance Syndrome or Altered Birth Weight in Danish Caucasians
J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1731 - 1734.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Ye, H. A. Young, X. Zhang, V. Castranova, V. Vallyathan, and X. Shi
Regulation of a Cell Type-specific Silencer in the Human Interleukin-3 Gene Promoter by the Transcription Factor YY1 and an AP2 Sequence-recognizing Factor
J. Biol. Chem., September 17, 1999; 274(38): 26661 - 26667.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. G. Wilson, J. A. Symons, T. L. McDowell, H. O. McDevitt, and G. W. Duff
Effects of a polymorphism in the human tumor necrosis factor alpha  promoter on transcriptional activation
PNAS, April 1, 1997; 94(7): 3195 - 3199.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Nirodi, J. Hart, P. Dhawan, N.-s. Moon, A. Nepveu, and A. Richmond
The Role of CDP in the Negative Regulation of CXCL1 Gene Expression
J. Biol. Chem., July 6, 2001; 276(28): 26122 - 26131.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.